neurologic progression

Related by string. Neurologic Progression * Neurologic : Ortho McNeil Neurologics . neurologic complications . neurologic symptoms . neurologic diseases . centered neurologic . neurologic disorders / Progressions . PROGRESSION . progressions . Progression : linear progression . chord progressions . chord progression . logical progression . geometric progression . harmonic progressions * *

Related by context. Frequent words. (Click for all words.) 69 FOLFIRI 68 plus prednisone 67 temsirolimus 67 chemoradiotherapy 67 mycophenolate mofetil 67 pertuzumab 66 mg kg dose 66 androgen deprivation 66 azacitidine 66 plus dexamethasone 66 fibrinolysis 65 nab paclitaxel 65 peginterferon alfa 2a 65 decitabine 65 median PFS 65 octreotide 65 disease progression 65 bosentan 64 topotecan 64 Torisel 64 mitoxantrone 64 axitinib 64 peginterferon 64 placebo controlled clinical 64 fluorouracil 64 glufosfamide 64 COPAXONE R 64 virologic response 64 pharmacodynamic effects 63 plus gemcitabine 63 XELOX 63 abiraterone acetate 63 dacarbazine 63 5 FU 63 vandetanib 63 achieved statistical significance 63 virologic 63 adalimumab 63 Secondary endpoints include 63 interferon therapy 63 Irinotecan 63 metastatic hormone refractory 63 plus methotrexate 63 tipranavir 63 administered subcutaneously 63 Secondary endpoints included 63 sustained virologic response 63 RECIST criteria 63 interferon alfa 63 etanercept 63 gemcitabine 63 dasatinib 63 cabazitaxel 63 Lenalidomide 63 Median survival 62 tumor regression 62 Gemcitabine 62 ziprasidone 62 virologic failure 62 tumor resection 62 peg IFN 62 cardiac toxicity 62 ZD# [001] 62 peginterferon alfa 2b 62 temozolomide 62 tolvaptan 62 evaluable 62 TORISEL 62 plus ribavirin 62 etoposide 62 neoadjuvant 62 tumor shrinkage 62 annualized relapse 62 mcg kg 62 imetelstat 62 unfractionated heparin 62 Fludara 62 infarct size 62 C1 INH 62 nilotinib 62 Jevtana 62 bortezomib 62 metastatic renal cell carcinoma 62 EBRT 62 Combination therapy 62 tanespimycin 62 CA4P 61 QTc 61 aripiprazole 61 statistically significant p = 61 Amrubicin 61 thromboembolic events 61 FOLFOX 61 tocilizumab 61 noninferiority 61 sunitinib 61 neoadjuvant chemotherapy 61 tumor lysis syndrome 61 distant metastasis 61 serum concentrations 61 mg QD

Back to home page